Invasive disease-free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.

Autor: Chew, S. M., Ferraro, E., Chen, Y., Barrio, A. V., Kelly, D., Modi, S., Seidman, A. D., Wen, H., Brogi, E., Robson, M., Dang, C. T.
Zdroj: NPJ Breast Cancer; 10/28/2024, Vol. 10 Issue 1, p1-6, 6p
Databáze: Complementary Index